Smad4 is an important tumor suppressor involved in TGF-β/BMP signaling[25], and patients with low expression of Smad4 tended to exhibit more poorly differentiated tumors, a higher risk of recurrence and shorter overall survival [26]. The gene discussed is SMAD4; the disease is neoplasm.